TABACCO, GAIA
 Distribuzione geografica
Continente #
AS - Asia 3.555
NA - Nord America 1.631
EU - Europa 689
SA - Sud America 223
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 33
OC - Oceania 9
Totale 6.189
Nazione #
SG - Singapore 2.647
US - Stati Uniti d'America 1.558
IT - Italia 376
CN - Cina 332
HK - Hong Kong 253
BR - Brasile 151
GB - Regno Unito 81
VN - Vietnam 77
BD - Bangladesh 68
FR - Francia 55
IN - India 49
DE - Germania 40
CA - Canada 33
IQ - Iraq 27
NL - Olanda 22
AR - Argentina 21
MX - Messico 19
IR - Iran 18
ES - Italia 17
CO - Colombia 16
FI - Finlandia 16
TR - Turchia 15
EC - Ecuador 12
ID - Indonesia 12
RU - Federazione Russa 9
UA - Ucraina 9
PH - Filippine 8
PS - Palestinian Territory 8
VE - Venezuela 8
AU - Australia 7
SE - Svezia 7
JP - Giappone 6
PL - Polonia 6
RO - Romania 6
SA - Arabia Saudita 6
AT - Austria 5
CL - Cile 5
CR - Costa Rica 5
EG - Egitto 5
GR - Grecia 5
LT - Lituania 5
PK - Pakistan 5
SN - Senegal 5
BE - Belgio 4
CZ - Repubblica Ceca 4
EE - Estonia 4
HR - Croazia 4
JM - Giamaica 4
MA - Marocco 4
MD - Moldavia 4
UG - Uganda 4
UY - Uruguay 4
YE - Yemen 4
ZA - Sudafrica 4
BG - Bulgaria 3
LY - Libia 3
NP - Nepal 3
PT - Portogallo 3
PY - Paraguay 3
TN - Tunisia 3
ET - Etiopia 2
HN - Honduras 2
KR - Corea 2
NI - Nicaragua 2
PE - Perù 2
SV - El Salvador 2
TH - Thailandia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MG - Madagascar 1
MS - Montserrat 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SX - ???statistics.table.value.countryCode.SX??? 1
TJ - Tagikistan 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
WS - Samoa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.142
Città #
Ashburn 406
San Jose 322
Hong Kong 238
Singapore 207
Rome 184
Dallas 107
Hefei 100
Beijing 89
Council Bluffs 74
Boardman 61
London 56
Columbus 55
Lauterbourg 43
Phoenix 43
Santa Clara 35
Shanghai 32
Ho Chi Minh City 29
Munich 24
New York 24
Los Angeles 20
Chicago 13
San Francisco 13
Turku 13
Milan 12
Hanoi 11
Washington 11
Boston 10
Rūpnagar 10
Montreal 9
Amsterdam 8
Atlanta 8
Frankfurt am Main 8
Las Vegas 8
Mexico City 8
Nablus 8
São Paulo 8
Buffalo 7
Naples 7
Brooklyn 6
Chennai 6
Genoa 6
Orem 6
Pune 6
Rio de Janeiro 6
Seattle 6
Stockholm 6
Biên Hòa 5
Campinas 5
Caracas 5
Dakar 5
Houston 5
Miami 5
Milton 5
Palermo 5
Porto Alegre 5
Quito 5
San José 5
Warsaw 5
Baghdad 4
Barcelona 4
Bogotá 4
Bologna 4
Brasília 4
Brno 4
Canberra 4
Da Nang 4
Haiphong 4
Jakarta 4
Kingston 4
Philadelphia 4
Sanaa 4
Tokyo 4
Toronto 4
Bari 3
Berlin 3
Bucharest 3
Cagayan de Oro 3
Cali 3
Catania 3
Curitiba 3
Esteio 3
Florence 3
Granada 3
Guayaquil 3
Helsinki 3
Iasi 3
Istanbul 3
Kampala 3
Mumbai 3
New Delhi 3
Santiago 3
St Louis 3
Tehran 3
Thái Bình 3
Adana 2
Agadir 2
Agra 2
Agugliano 2
Aigaleo 2
Alvorada 2
Totale 2.564
Nome #
A Novel Interplay Between Irisin and PTH: From Basic Studies to Clinical Evidence in Hyperparathyroidism 280
Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial 269
Point-of-Care device for measuring Thyroid function regulatory compounds in a biological fluid 245
Calcium citrate: from biochemistry and physiology to clinical applications 238
Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism 233
Bone quality in hypoparathyroidism 228
Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism 217
NOVEL APPROACHES TO EVALUATE BONE QUALITY IN PARATHYROID GLAND DISEASES 213
Evaluating the effect of calcifediol supplementation on seizure frequency in people with drug-resistant epilepsy 212
Denosumab discontinuation and the rebound phenomenon: A narrative review 174
CLINICAL, BIOCHEMICAL AND RADIOLOGICAL PROFILE OF NORMOCALCAEMIC HYPERPARATHYROIDISM: A MULTICENTRIC CROSS-SECTIONAL EVALUATION 157
Dipeptidyl Peptidase 3 Activity as a Promising Biomarker of Bone Fragility in Postmenopausal Women 152
A Rare Complication following Thyroid Percutaneous Ethanol Injection: Plummer Adenoma 146
Hobnail variant of papillary thyroid carcinoma showing goiter-like presentation and rapid growth 142
CARDIOVASCULAR AUTONOMIC NEUROPATHY CAUSES AN IMPAIRMENT OF QUALITY OF LIFE IN SUBJECTS WITH CHRONIC HYPOPARATHYROIDISM 140
DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism 140
A Pilot Study of Cognition Among Hypoparathyroid Adults 136
Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism 132
Bone and diabetes 130
Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism 128
A Rare and Severe Complication Following Thyroid Fine Needle Aspiration: Retropharyngeal Cellulitis 123
Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism 113
DXA-based bone strain index in normocalcemic primary hyperparathyroidism 110
Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism 104
Osteoanabolic and dual action drugs 99
Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety 92
Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma 89
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial 88
Two-Step Surgical Strategy for Parathyroid Carcinoma: A Single-Center Experience 83
Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. 83
PTH(1-34) for the primary prevention of postthyroidectomy hypocalcemia: The THYPOS trial 78
Real-Time Evaluation of Thyroid Cytology Using New Digital Microscopy Allows for Sample Adequacy Assessment, Morphological Classification, and Supports Molecular Analysis 77
Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy 77
Leg restlessness and hyperparathyroidism in Parkinson's disease, a further clue to RLS pathogenesis? 77
Irisin as a regulator of bone and glucose metabolism 77
Hypovitaminosis D: Is it time to consider the use of calcifediol? 77
Platelet function and markers of atherothrombotic risk in individuals with parathyroid disorders 77
Long-term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: A systematic review and meta-analysis 76
The impact of antiosteoporotic drugs on glucose metabolism and fracture risk in diabetes: Good or bad news? 75
PTH(1-34) for surgical hypoparathyroidism: A 2-year prospective, open-label investigation of efficacy and quality of life 71
Metabolic profile of human parathyroid adenoma 70
Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey 65
Irisin as a regulator of bone and glucose metabolism: a narrative review. 61
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 61
Management of Hypoparathyroidism 60
Patients diagnosed with low-risk thyroid cancer during coVid-19 pandemic: what did they ask surgeons? 60
Efficacy of radiofrequency and laser thermal ablation in solving thyroid nodule-related symptoms and cosmetic concerns. A systematic review and meta-analysis 55
PTH-driven modulation of platelet activity via the NOX2 pathway in postsurgical hypoparathyroidism 52
Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature 52
New Directions in Treatment of Hypoparathyroidism 48
IRISIN IN POSTMENOPAUSAL WOMEN WITH PRIMARY HYPERPARATHYROIDISM: AN INTERPLAY BETWEEN IRISIN AND PTH 45
PTH and bone material strength in hypoparathyroidism as measured by impact microindentation 43
Magnesium as an Endocrine Modulator: Physiological Roles, Clinical Evidence, and Therapeutic Perspectives 23
Anthropometric Indices and Markers of Atherothrombotic Risk in Subjects with Primary Hyperparathyroidism 22
Site-specific fracture risk in chronic hypoparathyroidism: systematic review and meta-analysis 14
Totale 6.189
Categoria #
all - tutte 29.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202263 0 0 0 0 2 0 0 0 15 0 0 46
2022/202375 2 0 1 1 2 0 5 0 7 6 43 8
2023/2024304 16 19 17 18 40 90 26 27 8 6 13 24
2024/20253.001 52 21 57 42 31 50 32 12 131 232 1.052 1.289
2025/20262.151 163 83 179 203 137 113 552 110 164 219 124 104
2026/2027591 45 195 232 119 0 0 0 0 0 0 0 0
Totale 6.189